Inventor
EMLING FRANZ
DE12 patents
⚠️ This page may combine multiple inventors who share the name “EMLING FRANZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BASF AG
9 patentsUS5231024AJul 27, 1993
Monoclonal antibodies against human tumor necrosis factor (tnf), and use thereof
BASF AG481 citations98
US6159962ADec 12, 2000
3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same
BASF AG36 citations92
US5831002ANov 3, 1998
Antitumor peptides
BASF AG42 citations92
US5180811AJan 19, 1993
Proteins having a tnf action comprising tnf-fibromectin fusion protein
BASF AG24 citations91
US6222034B1Apr 24, 2001
3-substituted pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use
BASF AG23 citations89
US5504189AApr 2, 1996
Peptides, their preparation and use
BASF AG9 citations73
US6387912B1May 14, 2002
Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
BASF AG7 citations72
US6159981ADec 12, 2000
3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same
BASF AG4 citations62
US5157106AOct 20, 1992
N-terminal deletions of lymphotoxin, their preparation and use
BASF AG0 citations48
ABBOTT LAB
3 patentsUS6355647B1Mar 12, 2002
3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use
ABBOTT LAB27 citations92
US6414157B1Jul 2, 2002
3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
ABBOTT LAB12 citations72
US6346622B1Feb 12, 2002
2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5HT1B and 5-HT1D)
ABBOTT LAB5 citations61